The systematic isolation of circulating regulatory peptides which generate cGMP as second messenger resulted in the identification of a novel member of the gnanylin family. In the present study we describe the purification and amino acid sequence of a new guanylate cyclase C activating peptide (GCAP-II). GCAP-II contains 24 amino acids in the following sequence: FKTLRTIANDDCELCVNVACTGCL. Its molecular mass is 2597.7 Da. The 16 C-terminal amino acids are identical to uroguanylin from human urine. Native and synthetic GCAP-II activate GC-C, the specific gnanylate cyclase receptor, of cultured human colon carcinoma (T84) cells. GCAP-II stimulates chloride secretion in isolated human intestinal mucosa mediated by intracellular cGMP increase. GCAP-II specific antibodies were used to localize the peptide by immunohistochemistry in entero-endocrine cells of the colonic mucosa.
Key words':Guanylate cyclase activating peptide II; Uroguanylin; Guanylin; cGMP; Intestinal chloride secretion; Entero-endocrine cell intestinal tissues, such as kidney, liver, reproductive tract, adrenals, airway epithelia, and pancreas [4,5]. In addition, a larger molecular form of this peptide, namely guanylin-22-115, circulates as a bioactive peptide in human blood, suggesting that this peptide regulates the function of different target organs by an endocrine interaction [8].Uroguanylin, a second ligand of the GC-C receptor, has been recently purified from human and opossum urine [9,10]. The structural homology and the similar biological activity of guanylin and uroguanylin suggest that they are members of a peptide family, the main function of which is the activation of GC-C in the intestine and in other tissues. With regard to putative endocrine interactions of this system we initiated a systematic search for further endogenous activators of GC-C circulating in human blood. Here we report the isolation, the biochemical and functional characterization, and the immunohistochemical localization of a new GCAP related to uroguanylin.